Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L8MO
|
|||
Former ID |
DIB003461
|
|||
Drug Name |
ME-3407
|
|||
Synonyms |
EF-4040; 2-(Butoxycarbonylmethylsulfinyl)thiazolo[5,4-b]pyridine; 2-(Thiazolo[5,4-b]pyridin-2-ylsulfinyl)acetic acid butyl ester
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Duodenal ulcer [ICD-11: DA63] | Phase 2 | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C12H14N2O3S2
|
|||
Canonical SMILES |
CCCCOC(=O)CS(=O)C1=NC2=C(S1)N=CC=C2
|
|||
InChI |
1S/C12H14N2O3S2/c1-2-3-7-17-10(15)8-19(16)12-14-9-5-4-6-13-11(9)18-12/h4-6H,2-3,7-8H2,1H3
|
|||
InChIKey |
BUXNKFNNJJTLOS-UHFFFAOYSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Myosin light kinase (MYLK) | Target Info | Inhibitor | [1] |
KEGG Pathway | Calcium signaling pathway | |||
cGMP-PKG signaling pathway | ||||
Vascular smooth muscle contraction | ||||
Focal adhesion | ||||
Platelet activation | ||||
Regulation of actin cytoskeleton | ||||
Oxytocin signaling pathway | ||||
Gastric acid secretion | ||||
Panther Pathway | Cytoskeletal regulation by Rho GTPase | |||
Inflammation mediated by chemokine and cytokine signaling pathway | ||||
Pathwhiz Pathway | Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin | |||
Muscle/Heart Contraction | ||||
Pathway Interaction Database | Aurora B signaling | |||
Reactome | Smooth Muscle Contraction | |||
WikiPathways | Regulation of Actin Cytoskeleton | |||
Focal Adhesion | ||||
Endothelin Pathways | ||||
Muscle contraction | ||||
MicroRNAs in cardiomyocyte hypertrophy |
References | Top | |||
---|---|---|---|---|
REF 1 | ME-3407, a new antiulcer agent, inhibits acid secretion by interfering with redistribution of H(+)-K(+)-ATPase. Am J Physiol. 1997 May;272(5 Pt 1):G1122-34. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.